Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Pfizer, PFE
PFE Earnings: Pfizer Stock Jumps on Q4 Beats
Pfizer (PFE) stock is up today after the pharmaceutical company reported earnings for the fourth quarter of 2024. The company’s adjusted EPS of
Pfizer (NYSE:PFE) Posts Better-Than-Expected Sales In Q4
Global pharmaceutical company Pfizer (NYSE:PFE) reported Q4 CY2024 results , with sales up 21.9% year on year to $17.76 billion. On the other hand, the company’s full-year revenue guidance of $62.5 billion at the midpoint came in 0.
Pfizer stock climbs on Q4 revenue and earnings beat, reaffirmed guidance
Pfizer’s adjusted fourth-quarter profit of 63 cents a share beat the FactSet consensus estimate of 47 cents a share. Revenue rose to $17.76 billion from $14.57 billion, and beat the FactSet consensus of $17.35 billion.
Pfizer: Q4 Earnings Snapshot
Pfizer expects full-year earnings in the range of $2.80 to $3 per share, with revenue in the range of $61 billion to $64 billion. This story was generated by Automated Insights ( http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PFE at https://www.zacks.com/ap/PFE
Pfizer beats Q4, FY '24 earnings estimates, stock down slightly in premarket trading
Pfizer (PFE) reported fourth quarter and full-year 2024 earnings results Tuesday, narrowly beating Wall Street expectations and sending the stock down about 1% in premarket trading. Pfizer reported $63.
Pfizer beats Q4, FY '24 earnings estimates, stock flat in premarket trading
Pfizer ( PFE) reported fourth quarter and full-year 2024 earnings results Tuesday, narrowly beating Wall Street expectations and sending the stock up about 1% in premarket trading.
Pfizer (PFE) Beats Q4 Earnings and Revenue Estimates
Pfizer (PFE) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.10 per share a year ago. These figures are adjusted for non-recurring items.
31m
on MSN
4 stocks to watch on Tuesday: PFE, GOOG/GOOGL and more
Here are some stocks to watch on Tuesday: ...
4h
Pfizer beats fourth-quarter profit estimates on cost-cutting efforts
U.S. drugmaker Pfizer beat Wall Street estimates for fourth-quarter profit on Tuesday, helped by cost-cutting efforts and ...
1d
If You Invested $10,000 In Pfizer Stock 10 Years Ago, How Much Would You Have Now?
Pfizer Inc. (NYSE:PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the ...
19h
on MSN
Pfizer Q4 Earnings Preview: Strong top line growth expected on COVID-19 product demand
Pfizer (PFE) is set to announce Q4 earnings, with analysts expecting a $0.46 profit per share and $17.26B revenue.
8h
on MSN
‘We can’t take any more houses, it’s destroying the community’
“It's not about whether we need more houses, it's about if we can add more with the infrastructure, and we are saying clearly ...
1d
Pfizer Trial For Colorectal Cancer Treatment Shows Improved Survival In Late-Stage Study
Pfizer's Braftovi combination showed significant survival benefits in a Phase 3 study for BRAF V600E-mutant metastatic ...
20h
on MSN
Jim Cramer on Pfizer Inc. (PFE): ‘The Stock Could Soar, Very Little Downside At These Low Levels’
We recently published an article titled Jim Cramer’s Game Plan: 15 Stocks in Focus. In this article, we are going to take a ...
2d
on MSN
Earnings week ahead: PLTR, AMZN, GOOG, AMD, LLY, PEP, F, PFE, MRK, PYPL and more
The first full week of February brings a packed earnings calendar, featuring major names across sectors. Tech giants Amazon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Pfizer
S&P 500 Index
COVID
New York Stock Exchange
Jim Cramer
Feedback